Critical Care / Anticoagulation Clinical Pharmacy Specialist | CVICU | Inova Heart and Vascular Institute
Falls Church, VA
Joined February 2012
- Tweets194
- Following368
- Followers100
- Likes1.3K
Mary Looby retweeted
Major reduction in bleeding with #ARIES trial in #LVAD pts. Now let’s improve #QOL and healthcare burden with #DOAC therapy. Read the DOAC LVAD study design paper.
@preventfailure @manreetkanwar @TomCascinoMD @rcogswell_umn @KeyurBShahRIC
Mary Looby retweeted
Just posted a photo @ Inova Fairfax Hospital instagram.com/p/CWyY1QLFW0S/…
Mary Looby retweeted
“It takes 10 years to become an overnight success.” - marathoners
“Hold my beer.” - Molly Seidel
#TeamUSA
Mary Looby retweeted
Happening now #ISHLT2021, UNC 90-pt study, no ASA in #LVAD patients from implant reduces hemocompatibility related adverse events. 6-fold higher risk of bleeding with ASA, no increase in stroke. @bradbumm @NirUrielMD @preventfailure @manreetkanwar @rcogswell_umn @tonkhueMdPhd
Mary Looby retweeted
A persistent enemy of excellence is fragmented attention.
On average, we check email 74x/day and switch tasks every 10min.
Computers are made for parallel processing. Humans are better at serial processing.
2021 resolution: focus on one task at a time.
fastcompany.com/944128/worke…
Mary Looby retweeted
One more post for #WorldRestartAHeart day ❤️
Mary Looby retweeted
The US has performed its first double lung transplant for lung damage caused by #COVID19. The recipient is a 20 yr old woman. She remains on a ventilator at this time. The damage inflicted by #SARSCoV2 is stunning. Via @nytimes
nytimes.com/2020/06/11/healt…
Mary Looby retweeted
COVID-19 and its implications for thrombosis and anticoagulation just out from @connors_md| Blood | American Society of Hematology ashpublications.org/blood/ar…
Mary Looby retweeted
New #COVID19 Treatment Guidelines published by the @NIH and developed by an expert panel including @SIDPharm representation from President-elect Dr. Susan Davis @IDPharmProf
These guidelines are available online and will be updated as new data emerge!
covid19treatmentguidelines.n…
Mary Looby retweeted
The authors describe a 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, along with two other critically ill patients with Covid-19 who were also seen in the same ICU. Coagulopathy and antiphospholipid antibodies were seen in all three patients. #COVID19
Mary Looby retweeted
The ISTH is committed to our mission to provide great education around #thrombosis and #hemostasis, so we are providing open access to our #COVID19 resource page and making all content on the ISTH Academy accessible for free. More: academy.isth.org/isth/#!*men…
Mary Looby retweeted
Let me build this out a little more. The below doesn't quite convey just how alarming the case trajectories are in the US.
We are in really, really bad shape, and getting worse.
Mary Looby retweeted
3 things I have learned about the #coronavirus crisis. 1. Hospitals are not the frontline in this war. You are. The medics treat the fallen. 2. The virus doesn’t spread. You spread it. 3. There is no medical solution yet (& maybe ever). You are the solution.
Mary Looby retweeted
#Lopinavir–#Ritonavir did not help patients #Hospitalized with Severe #COVID19. Please stop using #kaletra.
How important to do proper randomized trials.
#DontCoverDiscover #SARSCoV2 .@InfectiousDz .@onisillos .@IDstewardship .@IDSAInfo
nejm.org/doi/full/10.1056/NE…
Mary Looby retweeted
Higher co-infection rates (>20%) in COVID19 at Stanford med. Can't rely on stepwise triage algorithm. (E.g., Patient RSV or Flu+, enough chance of COVID19 that you can't rule it out) link.medium.com/alOn6PZLX4
Mary Looby retweeted
What will go down as the biggest breakdown in the US response to #COVID19 is the lack of test kits. South Korea and the US had their 1st patients on Jan 20 and Jan 21, respectively. Look at the difference in daily testing. By March 4th, SK was ~18,000 per day.
